Fonte: Clinical rheumatology. Unidade: FM
Assuntos: ECOCARDIOGRAFIA, INFLAMAÇÃO, ANQUILOSE, DOENÇAS CARDIOVASCULARES, PEPTÍDEO NATRIURÉTICO ATRIAL, FATORES DE RISCO, ESPONDILITE ANQUILOSANTE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MORAES, Julio C. B. et al. NT-proBNP levels may be influenced by inflammation in active ankylosing spondylitis receiving TNF blockers: a pilot study. Clinical rheumatology, v. 32, n. 6, p. 879-883, 2013Tradução . . Disponível em: http://link.springer.com/content/pdf/10.1007%2Fs10067-013-2182-x.pdf. Acesso em: 16 abr. 2026.APA
Moraes, J. C. B., Ribeiro, A. C. M., Saad, C. G. S., Lianza, A. C., Silva, C. A., & Bonfá, E. (2013). NT-proBNP levels may be influenced by inflammation in active ankylosing spondylitis receiving TNF blockers: a pilot study. Clinical rheumatology, 32( 6), 879-883. doi:10.1007/s10067-013-2182-xNLM
Moraes JCB, Ribeiro ACM, Saad CGS, Lianza AC, Silva CA, Bonfá E. NT-proBNP levels may be influenced by inflammation in active ankylosing spondylitis receiving TNF blockers: a pilot study [Internet]. Clinical rheumatology. 2013 ; 32( 6): 879-883.[citado 2026 abr. 16 ] Available from: http://link.springer.com/content/pdf/10.1007%2Fs10067-013-2182-x.pdfVancouver
Moraes JCB, Ribeiro ACM, Saad CGS, Lianza AC, Silva CA, Bonfá E. NT-proBNP levels may be influenced by inflammation in active ankylosing spondylitis receiving TNF blockers: a pilot study [Internet]. Clinical rheumatology. 2013 ; 32( 6): 879-883.[citado 2026 abr. 16 ] Available from: http://link.springer.com/content/pdf/10.1007%2Fs10067-013-2182-x.pdf
